EPHA1 and Alzheimer disease: In a Drosophila model of Alzheimer’s disease (AD) based on the AD-associated EphA1WT and EphA1P460L mutations, manipulation of Eph/ephrin levels in neurons affects sleep, neurophysiology and, memory, potentially linking these effects to AD pathology [96].